Nick Hartshorne-Evans the Founder and CEO of the Pumping Marvellous Foundation, the UK’s heart failure charity based in Preston, has been named in the New Year’s Honours list. Read more here pumpingmarvellous.org/new-year-honou… #NewYearsHonours

Great discussion from an amazing panel regarding #weightloss #obesity #BSHAM2024

Some great advice from the #dieticians regarding obesity and helping patients lose weight 🏃🥗👂#BSHAM2024

Last up today at the #BSHAM2024 🫀vs🫘 - I know who I have my money on (not biased as a cardiology nurse🤣)

Huge Congratulations to the Aneurin Bevan Health boards #heartfailure #consultantnurse Linda Edmunds MBE for her nomination of the #lindabloomaward at the #BSHAM2024. Thanks to Gwent #cardicrehab their support 💚

Ready for the #BSHAM2024 - Our #heartfailure Posters are up from the #ABUHB in #wales … and I have had coffee

Down in London for the #bsh2024; ready for 2 days of #heartfailure related learning🫀

Another GLP-1 drug success. Tirzepatide in heart failure with preserved ejection fraction (HFpEF) with longer term follow-up than 2 previous trials with semaglutide nejm.org/doi/full/10.... in people with BMI >30; no data yet for HFpEF in people without obesity

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM

Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor...

nejm.org